Propranolol in infantile haemangioma: simplifying pretreatment monitoring
BACKGROUND: Infantile haemangiomas (IHs) are very common vascular tumours. Propranolol is at present the first-line treatment for problematic and complicated haemangioma. In accordance with a Swiss protocol, children are monitored for 2 days at the start of the treatment to detect possible side...
Main Authors: | Oumama El Ezzi, Judith Hohlfeld, anthony de Buys Roessingh |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2014-02-01
|
Series: | Swiss Medical Weekly |
Subjects: | |
Online Access: | https://www.smw.ch/index.php/smw/article/view/1834 |
Similar Items
-
Excellent Response of Infantile Hemangioma with Oral Propranolol: A Case Report
by: Armyta Denissafitri, et al.
Published: (2022-11-01) -
Treatment outcomes of oral propranolol in the treatment of periocular infantile capillary hemangioma and factors predictive of recurrence and incomplete resolution: A multi-centric study
by: Sweety Tiple, et al.
Published: (2023-01-01) -
Oral atenolol compared to oral propranolol for infantile hemangioma
by: Victor Meza Viteri, et al.
Published: (2023-12-01) -
ORAL TOPICAL TIMOLOL MALEAT OR ORAL PROPRANOLOL TREATMENT FOR INFANTILE HEMANGIOMAS: CLINICAL ANALYSIS OF 403 PATIENTS
by: Terzi Özlem, et al.
Published: (2023-09-01) -
Oral propranolol for infantile hemangiomas: a prospective study on the role of 48-hour Holter monitoring in additional safety assessment
by: Jelena Petrovic, et al.
Published: (2017-08-01)